Literature DB >> 12228905

Hepatoblastoma with cholangioblastic features ('cholangioblastic hepatoblastoma') and other liver tumors with bimodal differentiation in young patients.

Arthur Zimmermann1.   

Abstract

In a subset of hepatoblastomas, differentiation of neoplastic cells can proceed along a pathway resulting in cholangiocyte-like cells. These cells either occur as single, immunohistochemically detectable elements, or form incomplete and complete duct-like profiles in continuation with embryonal, fetal or macrotrabecular hepatoblastoma components. As a working formulation it is proposed to employ the term, hepatoblastoma with cholangioblastic features (or 'cholangioblastic' hepatoblastoma), to denote such lesions. This bimodal differentiation presents itself in other rare tumors in the form of complex arrays of duct-like cells encircling nests of neoplastic hepatocyte lineage cells, in some way mimicking a ductal plate. A possible pathogenetic pathway is suggested, i.e., uni- or bipotential neoplastic progenitors switch into either of the two lineages. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2002        PMID: 12228905     DOI: 10.1002/mpo.10173

Source DB:  PubMed          Journal:  Med Pediatr Oncol        ISSN: 0098-1532


  9 in total

Review 1.  [Current status of diagnosis and treatment of hepatoblastoma].

Authors:  Purificación García-Miguel; Manuel López Santamaría
Journal:  Clin Transl Oncol       Date:  2005-08       Impact factor: 3.405

Review 2.  Primary malignant liver tumors in children.

Authors:  Sandeep Agarwala
Journal:  Indian J Pediatr       Date:  2012-03-01       Impact factor: 1.967

3.  Oncogenic signaling pathways and origins of tumor-initiating stem-like cells of hepatocellular carcinomas induced by hepatitis C virus, alcohol and/or obesity.

Authors:  Chia-Lin Chen; Hidekazu Tsukamoto; Keigo Machida
Journal:  Hepatol Int       Date:  2014-06-20       Impact factor: 6.047

Review 4.  'Teratoid' Hepatoblastoma: An Intriguing Variant of Mixed Epithelial-Mesenchymal Hepatoblastoma.

Authors:  Consolato M Sergi; Marta Rojas-Vasquez; Michelle Noga; Bryan Dicken
Journal:  Children (Basel)       Date:  2022-04-15

Review 5.  The SPLIT research agenda 2013.

Authors:  Estella M Alonso; Vicky L Ng; Ravinder Anand; Christopher D Anderson; Udeme D Ekong; Emily M Fredericks; Katryn N Furuya; Nitika A Gupta; Stacee M Lerret; Shikha Sundaram; Greg Tiao
Journal:  Pediatr Transplant       Date:  2013-05-30

Review 6.  International pediatric liver cancer pathological classification: current trend.

Authors:  Yukichi Tanaka; Takeshi Inoue; Hiroshi Horie
Journal:  Int J Clin Oncol       Date:  2013-10-18       Impact factor: 3.402

7.  Molecular Mechanisms of Hepatoblastoma.

Authors:  Yi Zhang; Antonio Solinas; Stefano Cairo; Matthias Evert; Xin Chen; Diego F Calvisi
Journal:  Semin Liver Dis       Date:  2021-01-20       Impact factor: 6.115

Review 8.  Novel therapeutic strategies for targeting liver cancer stem cells.

Authors:  Naoki Oishi; Xin Wei Wang
Journal:  Int J Biol Sci       Date:  2011-04-26       Impact factor: 6.580

Review 9.  The treatment of hepatoblastoma: Its evolution and the current status as per the SIOPEL trials.

Authors:  Daniel C Aronson; Piotr Czauderna; Rudolf Maibach; Giorgio Perilongo; Bruce Morland
Journal:  J Indian Assoc Pediatr Surg       Date:  2014-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.